Renal denervation is a minimal invasive procedure. It is used for the treatment of drug resistant or treatment resistant hypertension. This procedure reduces blood pressure by ablation of renal nerves. This procedure has certain benefits like shorter treatment timed permanent effects over drug treatment which in turn reduces the cost of treatment. These benefits tend to drive the market.
The global renal denervation devices market report provides market size (Revenue US$ Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).
The global renal denervation devices market segmentation is based on technology (renal sympathetic denervation procedure, radiofrequency-based renal denervation system, ultrasound-based renal denervation system, micro-infusion catheter-based renal denervation system), product or brand types (Simplicity Renal Denervation System, EnligHTN Multi-Electrode Renal Denervation System, OneShot, V2 Renal denervation System, PARADISE Technology, Surround Sound Renal Denervation System, TIVUS, Bullfrog Mocro-Infusion Catheters, Sound 360).
The global renal denervation devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global renal denervation devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.